News
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12
1 Apr 24
News, Price Target, Analyst Ratings
Femasys Q4 EPS $(0.19) Beats $(0.21) Estimate, Sales $213.11K Miss $240.00K Estimate
28 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Chardan Capital Reiterates Buy on Femasys, Maintains $12 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $10 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
21 Feb 24
Biotech, Government, News, Health Care, Financing, General
12 Health Care Stocks Moving In Monday's After-Market Session
19 Feb 24
Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
8 Feb 24
Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 Feb 24
Movers
Press releases
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeedĀ® for the Treatment of Infertility
20 Mar 24
Health Care, Press Releases
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
6 Feb 24
News, Management, Press Releases
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
26 Jan 24
Health Care, Press Releases